Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 9.35 is 49% below its 5-year average of 18.41, near the low end of its 5-year range (9.35–25.47).
As of the fiscal period ended Wednesday, December 31, 2025. 5.94% below its 12-month average of 9.94.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
9.35
EARNINGS PER SHARE (EPS) AVG TTM
9.94
EARNINGS PER SHARE (EPS) AVG 3Y
15.54
EARNINGS PER SHARE (EPS) AVG 5Y
18.41
EARNINGS PER SHARE (EPS) AVG 10Y
15.68
EARNINGS PER SHARE (EPS) AVG 15Y
13.15
EARNINGS PER SHARE (EPS) AVG 20Y
10.97
CURRENT VS TTM AVG
-5.94%
CURRENT VS 3Y AVG
-39.84%
CURRENT VS 5Y AVG
-49.20%
CURRENT VS 10Y AVG
-40.36%
CURRENT VS 15Y AVG
-28.90%
CURRENT VS 20Y AVG
-14.77%
Market Cap
$48.18B
Earnings Per Share (EPS)
1.88
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
Market Cap
$44.93B
Earnings Per Share (EPS)
13.56
TTM Avg
11.97
3Y Avg
10.56
5Y Avg
9.63
Market Cap
$40.61B
Earnings Per Share (EPS)
8.06
TTM Avg
7.74
3Y Avg
7.17
5Y Avg
5.87
Market Cap
$39.71B
Earnings Per Share (EPS)
4.98
TTM Avg
4.52
3Y Avg
4.36
5Y Avg
3.96
Market Cap
$54.46B
Earnings Per Share (EPS)
6.54
TTM Avg
4.98
3Y Avg
1.97
5Y Avg
-0.44
Market Cap
$38.51B
Earnings Per Share (EPS)
4.21
TTM Avg
0.10
3Y Avg
-3.15
5Y Avg
-4.54
Market Cap
$60.26B
Earnings Per Share (EPS)
3.95
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $46.67B | 9.35 | 9.94 | 15.54 | 18.41 |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 1.88 | 4.41 | 3.40 | 2.89 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 13.56 | 11.97 | 10.56 | 9.63 |
| IQVIA Holdings Inc. (IQV)vs › | $40.61B | 8.06 | 7.74 | 7.17 | 5.87 |
| Agilent Technologies, Inc. (A)vs › | $39.71B | 4.98 | 4.52 | 4.36 | 3.96 |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 6.54 | 4.98 | 1.97 | -0.44 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $38.51B | 4.21 | 0.10 | -3.15 | -4.54 |
| Medline Inc. (MDLN)vs › | $34.26B | 1.21 | 1.48 | 0.80 | 0.80 |
| Becton, Dickinson and Company (BDX)vs › | $60.26B | 3.95 | 5.86 | 5.65 | 5.38 |
| Zoetis Inc. (ZTS)vs › | $32.51B | 6.03 | 5.75 | 5.27 | 4.80 |
Trailing EPS (TTM)
$9.35
Forward EPS (Est.)
$8.98
P/E Ratio
40.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 9.87 |
| 2024-12-31 | 10.01 |
| 2023-12-31 | 20.09 |
| 2022-12-31 | 22.20 |
| 2021-12-31 | 22.79 |
| 2020-12-31 | 25.47 |
| 2019-12-31 | 20.19 |
| 2018-12-31 | 12.24 |
| 2017-12-31 | 16.94 |
| 2016-12-31 | 4.11 |
| 2015-12-31 | 8.54 |
| 2014-12-31 | 7.44 |
| 2013-12-31 | 7.82 |
| 2012-12-31 | 7.57 |
| 2011-12-31 | 8.58 |
| 2010-12-31 | 6.55 |
| 2009-12-31 | 6.21 |
| 2008-12-31 | 3.87 |
| 2007-12-31 | 5.00 |
| 2006-12-31 | 2.97 |
| 2005-12-31 | 1.91 |
| 2004-12-31 | 1.75 |
| 2003-12-31 | 1.41 |
| 2002-12-31 | 0.85 |
| 2001-12-31 | 0.71 |
| 2000-12-31 | 0.54 |
| 1999-12-31 | -2.28 |
| 1998-12-31 | 0.77 |
| 1997-12-31 | 1.06 |
| 1996-12-31 | 0.07 |
